- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02124720
Using Mobile Technology to Reduce Stereotypy
September 24, 2019 updated by: Marc Lanovaz, Université de Montréal
Using Mobile Technology to Reduce Stereotypy in Children With Autism Spectrum Disorders
Nearly all children with autism spectrum disorders engage in non-functional repetitive vocal and motor behaviours commonly referred to as stereotypy.
These repetitive behaviours may considerably interfere with the child's daily functioning, learning, and social inclusion.
As such, stereotypy generally has a negative impact on the child and family's health and quality of life.
Several behavioural interventions have been developed to reduce engagement in stereotypy in children with autism spectrum disorders, but the limited number of specialists available, the long waiting lists associated with public health services in Canada, and the high costs of private services have considerably restricted accessibility.
One potential solution to the limited availability and high costs of services is using a mobile application to recommend, teach, and monitor interventions designed to reduce engagement in stereotypy.
To this end, the purpose of the study is to evaluate the effects of the iSTIM (i.e., individualized Stereotypy Treatment Integrated Modules), a mobile application designed to assist parents in reducing stereotypy in children with autism spectrum disorders.
Specifically, we will assess whether the iSTIM correctly estimates the frequency or duration of stereotypy, offers suggestions consistent with recommended clinical practices, effectively reduces engagement in stereotypy, and is socially acceptable, safe, and easy to use for parents of children with autism spectrum disorders.
The results of the study will allow us to determine whether the mobile application may be used to treat this core symptom in children with autism spectrum disorders, which could potentially reduce waiting times and costs of providing health services to this population.
By reducing engagement in stereotypy, the iSTIM may also promote and facilitate the social participation as well as improve the quality of life and health of children with autism spectrum disorders and their families.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
39
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Mississauga, Ontario, Canada, L5L 5Y6
- Monarch House
-
-
Quebec
-
Montreal, Quebec, Canada, H8R 2H1
- CRDITED de Montréal
-
Montreal, Quebec, Canada
- Gold Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 12 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of autism spectrum disorders
- Must engage in at least one form of stereotypy
Exclusion Criteria:
- Stereotypy occurs less than 12 times per hour (or less than 20% of time)
- The form of stereotypy is potentially dangerous for the person (e.g., head banging, self-biting)
- The form of stereotypy is maintained by social consequences (e.g., attention, task avoidance)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mobile application
Use of the iSTIM mobile application 2 to 4 times per week over approximately 8 to 16 weeks
|
Trained research assistants and parents will implement the assessments and interventions recommended by the iSTIM mobile application during sessions lasting between 10 and 60 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency and duration of stereotypy
Time Frame: 2 to 4 times per week over 8 to 16 weeks
|
Direct observation of the frequency and duration of stereotypy during 10- to 60-minute sessions
|
2 to 4 times per week over 8 to 16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Social validity score
Time Frame: Immediately following the end of the intervention (i.e., after 8 to 16 weeks)
|
The user responds to a social validity questionnaire
|
Immediately following the end of the intervention (i.e., after 8 to 16 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Marc J Lanovaz, Ph.D., Université de Montréal
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2014
Primary Completion (Actual)
February 1, 2019
Study Completion (Actual)
February 1, 2019
Study Registration Dates
First Submitted
April 24, 2014
First Submitted That Met QC Criteria
April 24, 2014
First Posted (Estimate)
April 28, 2014
Study Record Updates
Last Update Posted (Actual)
September 26, 2019
Last Update Submitted That Met QC Criteria
September 24, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CERFAS-2014-15-030-P
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Child Development Disorders, Pervasive
-
Eunice Kennedy Shriver National Institute of Child...Yale UniversityTerminatedAutism | Pervasive Child Development DisordersUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH); University of Pittsburgh; Emory University and other collaboratorsCompletedChild Development Disorders, PervasiveUnited States
-
Rabin Medical CenterTerminatedChild Development Disorders, PervasiveIsrael
-
McGill University Health Centre/Research Institute...Canadian Institutes of Health Research (CIHR); University of AlbertaActive, not recruitingParent-Child Relations | Autism Spectrum Disorder | Parenting | Mental Health Wellness 1 | Parent-child Problem | Child Development Disorder | Child Developmental DelayCanada
-
Stanford UniversityJohn & Marcia Goldman FoundationRecruitingAutism Spectrum Disorder | Developmental Disability | Development Delay | Development Disorder, ChildUnited States
-
Ataturk UniversityPhd Nurgül KarakurtCompletedChild Development Disorders, Pervasive | Mother-Infant Interaction | Problems PsychosocialTurkey
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Hoffmann-La RocheCompletedMental Disorders | Neurodevelopmental Disorders | Autism Spectrum Disorder | Autistic Disorder | Child Development Disorders, PervasiveUnited Kingdom
-
Virginia Polytechnic Institute and State UniversityNational Institute of Mental Health (NIMH)CompletedAutistic Disorder | Child Development Disorders, PervasiveUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedAutism Spectrum Disorder | Autistic Disorder | Child Development Disorders, Pervasive | Autism | Asperger Syndrome | Pervasive Developmental DisorderUnited States
Clinical Trials on iSTIM
-
BlueWind MedicalRecruitingTreatment of Patients Suffering From Overactive Bladder (OAB)United States, Belgium, Netherlands, United Kingdom
-
University of California, Los AngelesRecruitingOveractive Bladder | Urgency-frequency Syndrome | Urinary Frequency More Than Once at NightUnited States